•  
• Tweet
•  
•  
•         Track Keywords
•  
• 

In the week ending November 4th 2022, a BNP Paribas survey found that global investors will ramp up allocations to distressed credit hedge funds next year, expecting opportunities to buy companies' debt on the cheap as tighter monetary policy from the Federal Reserve and other central banks weighs on growth.

Meanwhile, a report by Eurekahedge said that healthcare hedge funds declinedu887u 22.1% YTD but are well-placed to capitalize on current trends and grow returns. The first nine months of 2022 have been exceptionally challenging for the global financial markets, with rising geopolitical tensions, inflation, interest rates, recession concerns and the emergence of new, more transmissible variants of Covid-19 among an evergrowing list of worries that investors must grapple with, causing a spike in market volatility that has seen the CBOE Volatility Index rise 83.6% this year. Against this backdrop, the average healthcare hedge fund declined 22.1%, a disappointing return but still superior to the 24.8% fall of the S&P 500.

In performance news, Greenlight Capital got off to a very strong start in the fourth quarter, picking up right where it had left off in the prior quarter - the value-driven hedge fund firm surged 9.1 percent in October and is now up 28.4 percent for 2022; Bill Ackman's Pershing Square Holdings hedge fund gained almost 10 percent in October, slashing its year-to date-loss to 12 percent; Glenview Capital Management's three funds were profitable in October, with one of them moving into positive territory for 2022 - the firm's flagship fund, Glenview Capital Partners, gained 3.3 percent for the month, cutting its loss for the year to 9.7 percent; Sortis, a Portland, Oregon-based alternative investment fund manager, announced that the Sortis Income Fund, LLC produced a net annualized return of 8.02% du......................

To view our full article Click here